Colorado regulators have begun issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers” for supervised ingestion. The program is modeled after Oregon, where similar initiatives have been in place for nearly two years. Medical experts emphasize the need for further research into the potential therapeutic benefits of psilocybin and caution about the adverse effects, as well as the importance of gathering data to ensure safety.